PAPER Arroyo-Anlló EM, Díaz JP, Gil R

Familiar music as an enhancer of self-consciousness in patients with Alzheimer's disease.

Biomed Res Int. 2013;2013:752965. PubMed: 24106716

PAPER Velazquez P, Cribbs DH, Poulos TL, Tenner AJ

Aspartate residue 7 in amyloid beta-protein is critical for classical complement pathway activation: implications for Alzheimer's disease pathogenesis.

Nat Med. 1997 Jan;3(1):77-9. PubMed: 8986745

Rember TM

THERAPEUTICS 3,7-Bis(dimethylamino)phenothiazin-5-ium chloride TauRx Therapeutics Ltd Methylene Blue methylthioninium (MT) TRx-0014 Tau aggregation inhibitor (TAI) Small Molecule Tau The first trial known for Rember was a six-month Phase 2 study that ran between 2004

PAPER Rogers J, Schultz J, Brachova L, Lue LF, Webster S, Bradt B, Cooper NR, Moss DE

Complement activation and beta-amyloid-mediated neurotoxicity in Alzheimer's disease.

Res Immunol. 1992 Jul-Aug;143(6):624-30. PubMed: 1455054

PAPER Weis JH, Morton CC, Bruns GA, Weis JJ, Klickstein LB, Wong WW, Fearon DT

A complement receptor locus: genes encoding C3b/C4b receptor and C3d/Epstein-Barr virus receptor map to 1q32.

J Immunol. 1987 Jan 1;138(1):312-5. PubMed: 3782802

PAPER Birmingham DJ, Chen W, Liang G, Schmitt HC, Gavit K, Nagaraja HN

A CR1 polymorphism associated with constitutive erythrocyte CR1 levels affects binding to C4b but not C3b.

Immunology. 2003 Apr;108(4):531-8. PubMed: 12667215

PAPER Wong WW

Structural and functional correlation of the human complement receptor type 1.

J Invest Dermatol. 1990 Jun;94(6 Suppl):64S-67S. PubMed: 2141049

PAPER Liu D, Niu ZX

The structure, genetic polymorphisms, expression and biological functions of complement receptor type 1 (CR1/CD35).

Immunopharmacol Immunotoxicol. 2009;31(4):524-35. PubMed: 19874218

Michael Wolfe on Trans-dominant negative effects of pathogenic PSEN1 mutations on γ-secretase activity and Aβ production.

COMMENT Ray Kelleher's response to my comment on the Heilig et al. study reveals a serious misunderstanding about how detergents are employed in the study of membrane proteins. The major problem is the conflation of the detergent's role in membrane solu

PAPER Arachea BT, Sun Z, Potente N, Malik R, Isailovic D, Viola RE

Detergent selection for enhanced extraction of membrane proteins.

Protein Expr Purif. 2012 Nov;86(1):12-20. PubMed: 22963795

Chrysia-Maria Pegasiou

PAPER Ashani Y, Grunwald J, Kronman C, Velan B, Shafferman A

Role of tyrosine 337 in the binding of huperzine A to the active site of human acetylcholinesterase.

Mol Pharmacol. 1994 Mar;45(3):555-60. PubMed: 8145739

PAPER Wei G, Xiao S, Lu R, Liu C

Simultaneous determination of ZT-1 and its metabolite Huperzine A in plasma by high-performance liquid chromatography with ultraviolet detection.

J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Jan 2;830(1):120-5. Epub 2005 Nov 8 PubMed: 16288904

PAPER Bai DL, Tang XC, He XC

Huperzine A, a potential therapeutic agent for treatment of Alzheimer's disease.

Curr Med Chem. 2000 Mar;7(3):355-74. PubMed: 10637369

PAPER Ved HS, Koenig ML, Dave JR, Doctor BP

Huperzine A, a potential therapeutic agent for dementia, reduces neuronal cell death caused by glutamate.

Neuroreport. 1997 Mar 3;8(4):963-8. PubMed: 9141073